Indonesia Clinical Laboratory Market Outlook to 2026F (Second Edition)

Driven by Current Shortage, Widening Customer Base and Increasing Corporate Requirements For Clinical Testing

The report titled “Indonesia Clinical Laboratory Market Outlook to 2026F- Driven by Current Shortage, Widening Customer Base and Increasing Corporate Requirements For Clinical Testing” provides a comprehensive analysis of Clinical Laboratory Market in Indonesia. The report focuses on overall market size in terms of revenue generated by laboratories; Indonesia clinical laboratory Market Segmentation by Type of Independent Labs, type of payer, type of customers, types of tests, segmentation based on region and private hospitals. The report also covers the overall comparative landscape, trends and growth drivers, issues and challenge and government regulations. The report concludes with future projections and analyst recommendations highlighting the major opportunities and cautions.

Market Overview and Size

Indonesia Clinical Lab market was observed to grow with an augmenting growth rate in the review period 2016-2021. The Indonesia Clinical Lab market in terms of Revenue has increased at a positive CAGR of 11.5% during the review period 2016-2021. The growth was supported by increase in healthcare spending by aging population, expanding health insurance, growth in non-communicable disease and chronic diseases, rising disposable Income.

Market Segmentation

of Data Center Industry

• By Type of Labs: Clinical Laboratories can be recognized as Independent Labs, Private Hospital Labs and Public Hospital Labs. Public Hospital Labs have a majority in the Indonesian market followed by Private Hospital Labs.
• By Number of Labs: The labs can be recognized as public or private labs basis their ownership. Private Labs dominate the market in Indonesia.
• By Type of Private Independent Labs: In Indonesia, organized labs dominated the market share followed by unorganized labs. Majority of the organized labs are located in Java and Jakarta. This has been facilitated by increase in expenditure on health services, as people have become more health conscious.
• By Type of Payer: Corporates have accounted for the largest share of the number of tests in Indonesia. As the growing Indonesian workforce has led to an increase in corporate clients for pre-employment checks and annual health checks, more companies are engaging with private medical labs.
• By Type of Consumer (Basis Number of Tests): Majority of the patients who are consumer to these laboratories come through doctor referrals with majority market share based on the number of tests. Walk-ins and corporate clients respectively follow this.
• By Type of Tests: On the basis of type of tests the market is split between Routine, Esoteric and Non-laboratory tests. The most popular in the market are Routine tests. The non-laboratory tests account for a relatively small share of lab tests due to the additional licenses required to carry them out. Thus, laboratories are reluctant to do those tests.
• By Type of Routine Tests: The routine tests have different categories of tests. The leader in this category is CBC followed by Basic Metabolic Panel.
• By Esoteric tests: The esoteric tests have different categories of tests. The leader in this category is endocrine followed by infectious disease.
• By Region: Java, Jakarta and Bali have high rate of urbanization and more affluent population, which has created greater access and demand for private clinical laboratory testing services.
• By Private Hospital Labs: Private hospitals either have their own in-house labs or have a tie-up with a third party lab to accommodate their labs. In Indonesia in-house laboratories have a majority.

Competitive Landscape

The market is highly concentrated with the top private independent players being Prodia and Diagnos. Market is dominated by Prodia (PRDA). Kimia farma is the 2nd major player and Bio medika is the least contributor. CITO was designated by the Ministry of Health to be one of the laboratories for examining the coronavirus. This helped to be recognized across the region and thereby sustain footprints in the market. To capture the shift, industry leaders have started to implement initiatives such as retailer partnering, offering home testing, and enhancing engagement with patients through digital presence.

Future Outlook and Projections

Over the forecast period 2022-2026F, the Indonesia Clinical Lab Market Revenue is further anticipated to increase by year 2026F, thus showcasing a CAGR of 12.5%. It is expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories. Players, Investing to increase its testing capabilities and has adopted several advanced tests and technologies introduced in the global market, particularly specialized tests. Further, the major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market.

Key Segments Covered of Clinical Laboratory

By Type of Labs

• Independent Labs
• Private Hospital Labs
• Public Hospital Labs

By Number of Labs

• Private Labs
• Public Labs

By Type of Private Independent Labs:

• Organised
• Unorganised

By Type of payor:

• Corporates
• Out-Of-Pocket
• Private Insurance
• BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance Administration Organization)

By Type of Customer:

• Doctor Referral
• Corporates
• Walk-Ins
• External referrals
• Online Referrals

By Type of Tests:

• Routine
• Esoteric
• Non-Laboratory

By Type of routine tests

• CBC
• Basic Metabolic Panel
• A1C
• Others

By Type of Esoteric Tests

• Endocrine
• Infectious disease
• Allergic Disease
• Oncology
• Others

By Private Hospital Labs

• In-House
• Third Party

By Region

• Greater Jakarta
• West Java
• East Java, Bali, Nusa
• Aceh and North Sumatera
• Central Java
• Central Sumatera
• Sulawesi and Maluku
• Kalimantran
• Others

Key Target Audience

• Clinical Laboratory companies
• Organised Clinical Laboratories
• Unorganised Clinical Laboratories
• Private Hospitals
• Private Equity and Venture Capitalist
• Industry Associations
• Technology providers

Time Period Captured in the Report:

• Historical Period - 2016-2021
• Forecast Period - 2021-2026

Companies Covered:

Organised Laboratory Companies:

• Prodia
• Diagnos
• Pathlab
• Pramita
• Ultra Medica
• Kimia Farma
• Prima Medika
• Cito
• Parahita
• ABC Labs
• Bio Medika

Key Topics Covered in the Report

• Overview of Indonesia Clinical Laboratory Market
• Ecosystem of Major Entities in Indonesia Clinical Laboratory Market
• Business Cycle and Genesis of Indonesia Clinical Laboratory Market
• Indonesia Clinical Laboratory Market Size, 2016-2021

Indonesia Clinical Laboratory Market Segmentation

• Competition Analysis: Indonesia Clinical Laboratory Companies
• SWOT Analysis in Indonesia Clinical Laboratory Market
• Growth Drivers and Restraints in Indonesia Clinical Laboratory Market
• Technological Advancements in Indonesia Clinical Laboratory Market
• Impact of COVID19 in Malaysia Property Classified Market
• Key Trends in Indonesia Clinical Laboratory Market
• Outlook and Future Projections for Indonesia Clinical Laboratory Market
• Recommendations/Success Factors
• Research Methodology
• Appendix

 

Additional benefits of purchasing an enterprise license:

• TAM/SAM/SOM Analysis
• Customer Cohort Analysis
• Marketing Initiatives
• White Space Opportunity Analysis
• Interactive Data Visualizations
• Customization: 20 Analyst Hours
• 3 Months Post Sales Analyst Support
• Complimentary Update Next Year
• Custom Webinars